(Q45739887)

English

Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates

scientific article published on 30 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates (English)

1 reference

Europe PubMed Central

15 December 2017

Enterobacteriaceae

0 references

object named as

Brice Mouttet

2

0 references

author name string

Michael Hombach

1

1 reference

Europe PubMed Central

15 December 2017

Guido V Bloemberg

3

1 reference

Europe PubMed Central

15 December 2017

language of work or name

0 references

publication date

30 April 2013

1 reference

Europe PubMed Central

15 December 2017

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

15 December 2017

68

1 reference

Europe PubMed Central

15 December 2017

9

1 reference

Europe PubMed Central

15 December 2017

2092-2098

1 reference

Europe PubMed Central

15 December 2017

Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase-producing Enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

AmpC beta-lactamases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

EUCAST expert rules in antimicrobial susceptibility testing

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Expert systems in clinical microbiology

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

CTX-M: changing the face of ESBLs in Europe

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT136

21 January 2018

Identifiers

10.1093/JAC/DKT136

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45739887&oldid=2079881993"